查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1978836

攜帶式醫療影像設備市場：按產品類型、便攜性類型、應用和最終用戶分類－2026-2032年全球市場預測

Portable Diagnostic Imaging Market by Product Type, Portability Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，攜帶式醫療影像設備市場價值將達到 277.1 億美元，到 2026 年將成長至 300 億美元，到 2032 年將達到 496.9 億美元，複合年成長率為 8.70%。

主要市場統計數據
基準年 2025 277.1億美元
預計年份：2026年 300億美元
預測年份 2032 496.9億美元
複合年成長率 (%) 8.70%

權威地介紹了由小型化、互聯互通和臨床工作流程變革驅動的診斷影像快速去中心化進程。

攜帶式診斷影像技術已從固定於醫院放射科的專用設備發展成為涵蓋多種設備的生態系統，使診斷能力更貼近患者。這一轉變得益於技術的微型化、數位訊號處理的進步以及無線連接技術的成熟，使得設備能夠在臨床環境、現場環境和家庭環境中可靠運作。因此，醫療服務路徑變得更加分散，診斷可以在需要的地方進行，而不是集中在中心醫療機構。

小型化、軟體主導的生態系統、模組化互通性和供應鏈彈性如何共同作用，重塑攜帶式診斷成像設備的格局？

攜帶式診斷影像領域正經歷著一場由科技主導的劇變，這場變革正在改變臨床實務、採購模式和病患診療路徑。感測器的微型化和低場磁振造影架構的技術進步，使得更輕、更節能的設備成為可能，並能輕鬆部署在狹小空間內。同時，超音波診斷設備也正從笨重的主機發展成為手持式和智慧型手機連接設備，提供極其先進的成像功能，包括人工智慧影像輔助和自動化測量工具。這些創新降低了熟練操作人員的准入門檻，並將潛在用戶群擴展到診斷成像專業人員之外。

本研究評估了美國關稅措施在 2025 年的變化如何影響醫學影像領域的供應鏈策略、採購權衡和商業性差異化。

美國關稅的實施和逐步生效將持續到2025年，這對攜帶式診斷成像設備供應鏈中的製造商、經銷商和醫療保健採購負責人產生了切實的影響。影響關鍵零件、原料和組裝設備的關稅正在衝擊成本結構，促使企業重新評估籌資策略，並評估區域性製造地和售後服務地點的財務可行性。在許多情況下，企業正透過供應商多元化、增加庫存緩衝或加快組裝和測試流程的本地化來應對，以降低懲罰性關稅和運輸延誤帶來的風險。

將產品類型、便攜性、臨床應用、最終用戶、技術堆疊和價格範圍與策略決策流程。

攜帶式診斷成像市場的最佳理解方式是透過多層細分，揭示臨床需求、產品創新和商業性機會的交匯點。產品類型細分包括各種電腦斷層掃描 (CT)、分子影像、磁振造影 (MRI) 配置、超音波格式和 X 光解決方案。在此框架下，CT 又分為錐狀射束和螺旋兩種架構，分別針對不同的操作流程和空間權衡。分子影像分為正子斷層掃描 (PET) 和單光子發射電腦斷層掃描 (SPECT)，二者在示蹤劑處理和臨床應用方面各有不同。磁振造影技術則根據磁場強度和設計目的進一步細分，包括用於傳統成像的高場系統、兼顧性能和部署柔軟性的中場系統以及優先考慮便攜性的創新超低場系統。

美洲、歐洲、中東和非洲以及亞太地區的部署模式和現有基礎設施將決定攜帶式成像技術將在哪些地區廣泛應用。

區域趨勢對攜帶式診斷成像技術的應用模式、監管預期和商業策略起著決定性作用。在美洲，尤其重視與現有醫院網路的整合、床邊超音波診斷設備在急診和門診環境中的快速普及，以及獎勵處理能力和臨床療效顯著提升的報銷機制。在該地區，能夠與電子健康記錄和企業影像平台無縫整合的設備往往是優先考慮的因素，而服務網路和應對力則對供應商的選擇產生重大影響。

在競爭激烈的市場格局中，傳統製造能力、以硬體為中心的創新以及雲端和人工智慧夥伴關係關係的整合正在決定市場領導地位。

攜帶式診斷影像設備的競爭格局呈現出多元化的特點，既有成熟的原始設備製造商 (OEM)，也有專注於特定領域的創新企業，還有利用軟體和人工智慧技術提升診斷價值的敏捷型Start-Ups公司。老字型大小企業通常憑藉其豐富的產品系列、全球服務網路和完善的監管合規體系展開競爭，這些優勢有助於醫療機構進行大規模採購。為了維護醫療採購方的信任，這些成熟企業通常會在上市後監測、臨床研究和全面的培訓項目方面投入大量資金。

為設備製造商和醫療保健領導者提供可操作的策略重點，以確保攜帶式成像領域的臨床部署、供應彈性和永續的收入來源。

產業領導者應優先考慮整合價值提案，將硬體可靠性、軟體驅動的臨床效用和強大的售後支援相結合。積極投資於臨床證據和獨立檢驗研究，可以加快醫院採購委員會和認證機構的認可。同時，模組化產品架構允許軟體和連接方式升級，從而延長設備生命週期，並透過託管服務和訂閱模式創造持續收入。

採用穩健的混合方法研究途徑，結合對關鍵相關人員的訪談、技術文件的審查和三角測量分析，確保獲得可操作且檢驗的見解。

支持這些發現的研究採用了混合方法，旨在透過對一手和二手調查進行三角驗證來確保分析的嚴謹性。一手調查包括對臨床終端使用者、採購負責人以及急診醫學、放射學、居家醫療和軍事醫療服務領域的技術專家進行結構化訪談，並輔以與醫療設備製造業的產品經理和供應鏈負責人進行的諮詢。這些對話重點關注各種攜帶式設備和臨床應用的實際性能、可維護性問題以及推廣應用障礙。

將技術進步、臨床證據和營運韌性作為攜帶式成像持續成功的決定因素進行整合，得出相關結論。

攜帶式診斷成像正處於轉折點，這得益於技術進步、醫療服務模式的演變以及商業性創新，這些因素共同推動診斷範圍超越傳統醫療環境。具備可靠硬體、靈活軟體生態系統、完善售後服務和明確臨床證據的設備，最能滿足日益成長的現場診斷需求。因此，市場參與企業必須平衡創新速度與卓越運營，確保新產品上市的同時，配套完善的服務模式與整合方案能有效降低使用者接受度。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：攜帶式醫療影像設備市場：依產品類型分類

  • CT
    • 錐狀射束CT
    • 螺旋CT
  • 分子影像
    • PET
    • SPECT
  • MRI
    • 高磁場
    • 中等磁場
    • 超低磁場
  • 超音波
    • 2D
    • 3D
    • 多普勒
    • 手持式
      • 專用終端
      • 基於智慧型手機
    • 無線的
      • 藍牙相容
      • 具備 Wi-Fi 功能
  • X光
    • 電腦放射成像
    • 數位放射線攝影

第9章：按便攜性類型分類的攜帶式醫療影像設備市場

  • 手持式
    • 專用終端
    • 配備智慧型手機的
  • 筆記型電腦安裝
    • 標準整合
    • 平板電腦整合
  • 手推車式
    • 交流電源
    • 電池供電

第10章：攜帶式醫療影像設備市場：依應用領域分類

  • 緊急狀況
    • 重症監護
    • 創傷
  • 居家照護
    • 慢性病監測
    • 老年護理
  • 軍隊
    • 戰區
    • 野戰醫院
  • 照護端
    • 腹部
    • 心臟病學
    • 肌肉骨骼系統
    • 產科
    • 血管
  • 獸醫學
    • 大型動物
    • 小動物

第11章：攜帶式醫療影像設備市場：依最終用戶分類

  • 診所
    • 政府
    • 私人的
  • 診斷中心
    • 診斷影像中心
    • 檢查室
  • 居家照護提供者
    • 私人的
    • 公共機構
  • 醫院
    • 整體的
    • 專科醫療部門
  • 門診部
    • 門診手術
    • 復原

第12章：攜帶式醫療影像設備市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：攜帶式醫療影像設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章攜帶式醫療影像設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國攜帶式醫療影像設備市場

第16章：中國攜帶式醫療影像設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Agfa-Gevaert NV
  • Akumin Inc
  • Butterfly Network, Inc.
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • Cobalt Health
  • CurveBeam LLC
  • Esaote SpA
  • Esaote SpA
  • Front Range Mobile Imaging
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies Inc
  • Hitachi Ltd.
  • Hologic, Inc.
  • Hyperfine Inc.
  • Koninklijke Philips NV
  • Medtronic PLC
  • Nox Medical
  • OMRON Corporation
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Toshiba Medical Systems Corporation
  • TridentCare, LLC
  • TTG Imaging Solutions, LLC
Product Code: MRR-2A0283E25686

The Portable Diagnostic Imaging Market was valued at USD 27.71 billion in 2025 and is projected to grow to USD 30.00 billion in 2026, with a CAGR of 8.70%, reaching USD 49.69 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 27.71 billion
Estimated Year [2026] USD 30.00 billion
Forecast Year [2032] USD 49.69 billion
CAGR (%) 8.70%

An authoritative introduction to the rapid decentralization of diagnostic imaging driven by miniaturization, connectivity, and clinical workflow transformation

Portable diagnostic imaging has evolved from specialist equipment tethered to hospital imaging suites into a diverse ecosystem of devices that push diagnostic capacity closer to the patient. This transition is driven by technological miniaturization, advances in digital signal processing, and the maturation of wireless connectivity, which together enable devices to operate reliably in clinical, field, and domiciliary settings. As a result, care pathways are becoming more decentralized, with diagnostics delivered at the point of need rather than being concentrated in central facilities.

The convergence of imaging modalities with cloud computing and edge analytics is reshaping clinical workflows and enabling faster triage decisions. Clinicians are using portable CT, MRI variants, ultrasound, molecular imaging, and compact X-ray systems to gather actionable information that previously required patient transport and scheduling delays. From emergency response to home-based chronic disease monitoring, these technologies expand the reach of diagnostic services and support timelier interventions. In parallel, design priorities have shifted toward ergonomic form factors, power efficiency, and simplified user interfaces to minimize training burdens and streamline integration into non-traditional care settings.

Regulatory scrutiny and interoperability standards are increasingly central to product development cycles, and stakeholder expectations for data security and clinical validation are rising. Adoption is therefore mediated not only by device performance, but also by the extent to which vendors can demonstrate robust clinical evidence, reliable lifecycle support, and secure data management. This introduction frames the subsequent analysis by highlighting where the sector is now, the forces shaping near-term competitive advantage, and the operational considerations that will decide which portable imaging solutions achieve broad, sustained adoption.

How miniaturization, software-driven ecosystems, modular interoperability, and supply chain resilience are collectively reshaping portable diagnostic imaging dynamics

The landscape of portable diagnostic imaging is undergoing profound, technology-led shifts that are transforming clinical practice, procurement models, and patient pathways. Technological advances in sensor miniaturization and low-field MRI architectures are enabling devices that are lighter, more energy-efficient, and easier to deploy in constrained environments. Simultaneously, ultrasound systems have progressed from bulky consoles to handheld instruments and smartphone-integrated devices that offer surprisingly sophisticated imaging capabilities, supported by AI-assisted interpretation and automated measurement tools. These innovations lower the barrier to skilled operation and expand the pool of potential users beyond imaging specialists.

Connectivity and software-defined functionality are also creating new value layers. Cloud-enabled platforms and edge computing allow for secure image transfer, remote consultation, and continuous software improvement without hardware replacement. This increases device lifespan and enables subscription-style software monetization. At the same time, modularity and platform approaches are promoting interoperability across modalities, making it simpler for institutions to integrate portable units into existing clinical information systems. Consequently, purchasing decisions are increasingly influenced by a device's ecosystem compatibility and long-term software roadmap rather than by hardware features alone.

Clinical workflow paradigms are shifting as emergency departments, outpatient centers, and home care providers integrate point-of-care imaging to expedite diagnosis. This evolution is supported by reimbursement adjustments in some jurisdictions and by operational incentives to reduce patient throughput times. Finally, supply chain resilience and geographic diversification of component sourcing have become strategic priorities following recent global disruptions, prompting many manufacturers to rethink sourcing strategies and to increase localization of critical components. Together, these transformative shifts are redefining competitive advantage in portable diagnostic imaging and setting the agenda for product roadmaps, commercial models, and regulatory engagement.

Assessing how evolving United States tariff measures through 2025 have reshaped supply chain strategy, procurement trade-offs, and commercial differentiation in imaging

The imposition and evolution of tariffs by the United States through 2025 have had tangible implications for manufacturers, distributors, and healthcare buyers within the portable diagnostic imaging supply chain. Tariffs affecting key components, raw materials, and assembled devices influence cost structures, prompting firms to reassess sourcing strategies and to evaluate the financial viability of regional manufacturing and aftermarket support hubs. In many cases, companies have responded by diversifying supplier bases, increasing inventory buffers, or accelerating localization of assembly and testing processes to mitigate exposure to punitive duties and transit delays.

These shifts are not limited to cost considerations. Tariffs interact with regulatory compliance and logistics complexity to shape go-to-market timing and pricing transparency. Providers that rely on cross-border procurement may encounter longer lead times and more complex warranty administration. Consequently, procurement teams and clinical leaders must weigh the trade-offs between short-term acquisition cost savings and longer-term serviceability, spare-part availability, and lifecycle total cost of ownership. In parallel, firms are revisiting distribution models to reduce tariff drag, for example by establishing regional distribution nodes or by partnering with local contract manufacturers to perform final assembly in tariff-friendly jurisdictions.

Moreover, the tariff environment has intensified competitive differentiation around non-price attributes such as clinical evidence, software services, and integrated training programs. As cost pressures ripple through the value chain, companies that offer robust remote support, predictable maintenance schedules, and clear upgrade paths for cloud and AI-enabled services tend to retain customer trust despite price volatility. Finally, public procurement policies that factor in supply chain security and regional industrial policy are increasingly influencing vendor selection, underscoring the need for transparency and resilience in sourcing and operational planning.

Comprehensive segmentation insights connecting product types, portability formats, clinical applications, end users, technology stacks, and price tiers to strategic decision pathways

The portable diagnostic imaging market is best understood through layered segmentation that reveals where clinical demand, product innovation, and commercial opportunity intersect. Product-type differentiation spans computed tomography variants, molecular imaging, magnetic resonance configurations, ultrasound formats, and X-ray solutions. Within this framework, CT diverges into cone beam and helical architectures, each addressing different procedural and spatial trade-offs. Molecular imaging splits into positron emission tomography and single photon systems, which have distinct tracer logistics and clinical use cases. Magnetic resonance technology is further stratified by field strength and design intent, encompassing high-field systems for conventional imaging, mid-field systems that balance performance and deployment flexibility, and ultra-low-field innovations that prioritize portability.

Ultrasound exemplifies breadth within portability, ranging from traditional two-dimensional devices to three-dimensional and Doppler-capable platforms suited for vascular and cardiology applications. The handheld segment introduces both dedicated devices and smartphone-integrated options, while wireless configurations include Bluetooth-enabled and Wi-Fi-enabled models, each with different implications for connectivity, security, and integration. X-ray follows a similar bifurcation between computed radiography and fully digital radiography approaches, emphasizing differences in image processing workflows and onsite storage requirements. Portability type further segments the market into handheld, laptop-based, and trolley-based solutions; handheld devices differentiate between dedicated hardware and smartphone-based systems, laptop-based systems may be integrated in standard or tablet forms, and trolley-based platforms present AC-operated or battery-operated variants, with corresponding implications for mobility and deployment scenarios.

Application-driven segmentation highlights the clinical contexts where portable imaging delivers the most value. Emergency use cases split into critical care and trauma workflows where rapid diagnostics are essential, while home care supports chronic disease monitoring and elderly care. Military deployments must accommodate combat zone and field hospital constraints, and point-of-care applications cover abdominal, cardiology, musculoskeletal, obstetrics, and vascular indications. Veterinary uses bifurcate into large animal and small animal modalities, each with distinct form factor and durability requirements. End-user segmentation spans clinics, diagnostic centers, home care providers, hospitals, and outpatient centers; within these categories, ownership models and institutional types-government versus private clinics, imaging centers versus laboratories, private versus public home care providers, general versus specialty hospitals, and ambulatory surgical versus rehabilitation outpatient centers-shape procurement cycles and support expectations.

Technology and price-range segmentations also play critical roles. Analog versus digital divides the market along workflow modernization lines, with film-based analog approaches giving way to cloud-enabled and on-premise digital infrastructures that alter image access and archival strategies. Price tiers-from economy low-end devices to mid-range entry and standard models and up to premium and ultra-premium high-end offerings-drive different value propositions, where high-end solutions emphasize advanced imaging capability and comprehensive service contracts, while low-end devices prioritize affordability and basic diagnostic utility. Together, these segmentation lenses provide a detailed map for vendors and buyers to assess where to focus product development, clinical validation, and commercial investment to meet nuanced customer needs.

Regional adoption patterns and infrastructure realities across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine where portable imaging gains traction

Regional dynamics play a decisive role in adoption patterns, regulatory expectations, and commercial strategies for portable diagnostic imaging. In the Americas, there is a pronounced emphasis on integration with established hospital networks, rapid adoption of point-of-care ultrasound in emergency and ambulatory settings, and a reimbursement landscape that rewards demonstrable improvements in throughput and clinical outcomes. Procurement cycles in this region often prioritize devices that can integrate seamlessly with electronic health records and enterprise imaging platforms, and vendor selection is heavily influenced by service networks and responsiveness.

Europe, Middle East & Africa presents a heterogeneous landscape in which regulatory frameworks, reimbursement incentives, and capital availability vary widely. In parts of Europe, centralized procurement and strong clinical governance favor solutions with robust evidence packages and interoperability credentials. Meanwhile, Middle Eastern markets often prioritize rapid deployment capabilities and localized support, and sub-Saharan African contexts place a premium on durability, energy efficiency, and straightforward maintenance protocols. Across this combined region, opportunities exist for vendors that can offer adaptable service models and durable designs that address infrastructure variability.

Asia-Pacific exhibits dynamic demand driven by urbanization, expanding primary care capacity, and significant investments in healthcare infrastructure. Several countries in the region are advancing telemedicine and home healthcare initiatives that rely on portable imaging for remote diagnostics and chronic care management. Additionally, a growing domestic manufacturing base and evolving regulatory infrastructures influence procurement decisions, with buyers seeking scalable, cost-effective devices that can be supported across diverse geographies. These regional profiles underscore the importance of tailoring product feature sets, service offerings, and commercial approaches to local clinical practices, reimbursement environments, and infrastructure realities.

Competitive landscape dynamics where legacy manufacturing strength, focused hardware innovation, and cloud and AI partnerships converge to determine market leadership

The competitive landscape in portable diagnostic imaging is characterized by a mix of established original equipment manufacturers, specialized niche innovators, and agile startups leveraging software and AI to add diagnostic value. Established firms often compete on breadth of product portfolios, global service networks, and established regulatory pathways that facilitate large-scale procurement by health systems. These incumbents typically invest heavily in post-market surveillance, clinical studies, and comprehensive training programs to maintain trust among institutional buyers.

Concurrently, specialized firms and newer entrants are driving disruption through focused innovations in handheld ultrasound, low-field magnetic resonance systems, and compact CT designs. Their strengths lie in rapid iteration, targeted clinical validation in specific use cases, and business models oriented around software subscriptions and managed services. Partnerships between hardware developers and software or cloud providers are increasingly common, enabling devices to offer enhanced image processing, decision support, and teleconsultation capabilities. This collaboration model lowers barriers for clinical adoption by addressing interpretation bottlenecks and by enabling remote expert support.

Mergers, strategic alliances, and licensing agreements are recurrent themes, as companies seek to combine hardware competencies with advanced software capabilities and regional distribution expertise. Supply chain integration and serviceability remain competitive differentiators, particularly for buyers in decentralized care settings who prioritize uptime and local maintenance. Intellectual property in imaging reconstruction algorithms, low-power hardware designs, and AI-enabled diagnostic aids is also a critical axis of competitive advantage, with firms that can protect and commercialize these assets better positioned to capture long-term value. Overall, the company landscape rewards those who can balance product reliability with software-enabled clinical value and resilient support infrastructure.

Actionable strategic priorities for device makers and healthcare leaders to secure clinical adoption, supply resilience, and recurring revenue streams in portable imaging

Industry leaders should prioritize an integrated value proposition that pairs hardware reliability with software-enabled clinical utility and resilient post-sale support. Investing proactively in clinical evidence generation and independent validation studies will accelerate acceptance among hospital procurement committees and credentialing bodies. At the same time, modular product architectures that allow upgrades to software and connectivity features can extend device lifecycles and create recurring revenue through managed services and subscription models.

Operationally, companies should diversify supply chains and consider regional final assembly or contract manufacturing to mitigate tariff and logistics exposure. Building capacity for remote diagnostics, predictive maintenance, and spare-part forecasting will reduce downtime and strengthen customer trust, especially in decentralized care settings. Commercial strategies should emphasize partnerships with telehealth platforms, electronic health record vendors, and local service organizations to ensure seamless integration and to lower adoption friction for end users. Pricing and reimbursement strategies must be aligned with demonstrated clinical and operational benefits; value-based contracting pilots can help capture part of the efficiency gains delivered by point-of-care imaging.

Finally, investing in training programs, intuitive user interfaces, and clinician-facing decision support will broaden the addressable user base and reduce reliance on specialist operators. By combining clinical validation, software flexibility, supply chain resilience, and service excellence, industry leaders can turn current disruptions into durable competitive advantages and drive broader adoption across both institutional and non-institutional care settings.

A robust mixed-methods research approach combining primary stakeholder interviews, technical document review, and triangulated analysis to ensure actionable and validated insights

The research underpinning these insights employed a mixed-methods approach designed to triangulate primary and secondary evidence and to ensure analytical rigor. Primary research included structured interviews with clinical end users, procurement officers, and technical specialists across emergency medicine, radiology, home care, and military medical services, complemented by consultations with product managers and supply chain leaders in device manufacturing. These conversations focused on real-world performance, serviceability concerns, and adoption barriers across a range of portability formats and clinical applications.

Secondary research involved systematic review of peer-reviewed clinical studies, regulatory filings, product technical specifications, and industry whitepapers that document device performance characteristics, safety profiles, and interoperability features. Where available, authoritative standards and guidance from regulatory agencies were consulted to contextualize compliance requirements and to assess evidence expectations for clinical deployment. Data from logistics and trade publications informed analysis of supply chain patterns and tariff-related impacts, while technology trend reports helped frame developments in miniaturization, connectivity, and AI-enabled image analysis.

Analytical techniques included comparative feature mapping across segmentation lenses, scenario analysis to evaluate supply chain and tariff contingencies, and cross-validation of primary insights against documented product performance. Limitations of the methodology include variability in published clinical evidence across device classes and regional heterogeneity in procurement and reimbursement policies. To mitigate these limitations, findings were validated with multiple independent stakeholders and subjected to sensitivity checks to ensure robustness of conclusions. The resulting framework combines empirical observation with strategic interpretation to support decision-making for manufacturers, providers, and investors.

Concluding synthesis that aligns technology progress, clinical evidence, and operational resilience as the determinants of enduring success in portable imaging

Portable diagnostic imaging is at an inflection point where technological progress, changing care delivery models, and commercial innovation converge to expand diagnostic reach beyond traditional settings. Devices that marry dependable hardware with flexible software ecosystems, strong post-sale support, and clear clinical evidence will be best placed to capture the growing demand for point-of-need diagnostics. Market participants must therefore balance innovation velocity with operational excellence, ensuring that new product introductions are accompanied by service models and integration pathways that reduce adoption friction.

Regulatory, tariff, and supply chain pressures require strategic foresight, including reinforcement of sourcing strategies, investment in regional support capabilities, and transparent engagement with buyers about lifecycle costs. Clinical leaders and procurement teams should prioritize devices that demonstrate interoperability, security, and measurable impact on clinical workflows. Ultimately, the most successful solutions will be those that deliver reliable, user-friendly imaging in contexts where speed and access materially improve patient outcomes and system efficiency.

By aligning product development with validated clinical needs and by building resilient commercial and operational infrastructures, stakeholders can accelerate adoption and sustainably embed portable diagnostic imaging into diverse care pathways. The sector's momentum offers a compelling opportunity for those willing to invest in evidence, serviceability, and platform-driven value creation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Portable Diagnostic Imaging Market, by Product Type

  • 8.1. CT
    • 8.1.1. Cone Beam CT
    • 8.1.2. Helical CT
  • 8.2. Molecular Imaging
    • 8.2.1. PET
    • 8.2.2. SPECT
  • 8.3. MRI
    • 8.3.1. High Field
    • 8.3.2. Mid Field
    • 8.3.3. Ultra Low Field
  • 8.4. Ultrasound
    • 8.4.1. 2D
    • 8.4.2. 3D
    • 8.4.3. Doppler
    • 8.4.4. Handheld
      • 8.4.4.1. Dedicated Device
      • 8.4.4.2. Smartphone Based
    • 8.4.5. Wireless
      • 8.4.5.1. Bluetooth Enabled
      • 8.4.5.2. Wi-Fi Enabled
  • 8.5. X-Ray
    • 8.5.1. Computed Radiography
    • 8.5.2. Digital Radiography

9. Portable Diagnostic Imaging Market, by Portability Type

  • 9.1. Handheld
    • 9.1.1. Dedicated Device
    • 9.1.2. Smartphone Based
  • 9.2. Laptop Based
    • 9.2.1. Standard Integration
    • 9.2.2. Tablet Integration
  • 9.3. Trolley Based
    • 9.3.1. AC Operated
    • 9.3.2. Battery Operated

10. Portable Diagnostic Imaging Market, by Application

  • 10.1. Emergency
    • 10.1.1. Critical Care
    • 10.1.2. Trauma
  • 10.2. Home Care
    • 10.2.1. Chronic Disease Monitoring
    • 10.2.2. Elderly Care
  • 10.3. Military
    • 10.3.1. Combat Zone
    • 10.3.2. Field Hospital
  • 10.4. Point Of Care
    • 10.4.1. Abdominal
    • 10.4.2. Cardiology
    • 10.4.3. Musculoskeletal
    • 10.4.4. Obstetrics
    • 10.4.5. Vascular
  • 10.5. Veterinary
    • 10.5.1. Large Animal
    • 10.5.2. Small Animal

11. Portable Diagnostic Imaging Market, by End User

  • 11.1. Clinics
    • 11.1.1. Government
    • 11.1.2. Private
  • 11.2. Diagnostic Centers
    • 11.2.1. Imaging Centers
    • 11.2.2. Laboratories
  • 11.3. Home Care Providers
    • 11.3.1. Private
    • 11.3.2. Public
  • 11.4. Hospitals
    • 11.4.1. General
    • 11.4.2. Specialty
  • 11.5. Outpatient Centers
    • 11.5.1. Ambulatory Surgical
    • 11.5.2. Rehabilitation

12. Portable Diagnostic Imaging Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Portable Diagnostic Imaging Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Portable Diagnostic Imaging Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Portable Diagnostic Imaging Market

16. China Portable Diagnostic Imaging Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Agfa-Gevaert N.V.
  • 17.7. Akumin Inc
  • 17.8. Butterfly Network, Inc.
  • 17.9. Canon Medical Systems Corporation
  • 17.10. Carestream Health, Inc.
  • 17.11. Cobalt Health
  • 17.12. CurveBeam LLC
  • 17.13. Esaote S.p.A
  • 17.14. Esaote SpA
  • 17.15. Front Range Mobile Imaging
  • 17.16. FUJIFILM Holdings Corporation
  • 17.17. GE HealthCare Technologies Inc
  • 17.18. Hitachi Ltd.
  • 17.19. Hologic, Inc.
  • 17.20. Hyperfine Inc.
  • 17.21. Koninklijke Philips N.V.
  • 17.22. Medtronic PLC
  • 17.23. Nox Medical
  • 17.24. OMRON Corporation
  • 17.25. Shimadzu Corporation
  • 17.26. Siemens Healthineers AG
  • 17.27. Toshiba Medical Systems Corporation
  • 17.28. TridentCare, LLC
  • 17.29. TTG Imaging Solutions, LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABILITY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HELICAL CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HELICAL CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HELICAL CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SPECT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SPECT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SPECT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH FIELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH FIELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH FIELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MID FIELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MID FIELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MID FIELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA LOW FIELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA LOW FIELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA LOW FIELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 2D, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 2D, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 2D, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 3D, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 3D, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 3D, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BLUETOOTH ENABLED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BLUETOOTH ENABLED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BLUETOOTH ENABLED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WI-FI ENABLED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WI-FI ENABLED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WI-FI ENABLED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY STANDARD INTEGRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY STANDARD INTEGRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY STANDARD INTEGRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TABLET INTEGRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TABLET INTEGRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TABLET INTEGRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY AC OPERATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY AC OPERATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY AC OPERATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BATTERY OPERATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BATTERY OPERATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BATTERY OPERATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CRITICAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CRITICAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CRITICAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TRAUMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TRAUMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TRAUMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ELDERLY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ELDERLY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ELDERLY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMBAT ZONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMBAT ZONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMBAT ZONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY FIELD HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY FIELD HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY FIELD HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ABDOMINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ABDOMINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ABDOMINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY OBSTETRICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY OBSTETRICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY OBSTETRICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY VASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY VASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY VASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY VETERINARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY VETERINARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY VETERINARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LARGE ANIMAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LARGE ANIMAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LARGE ANIMAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMALL ANIMAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMALL ANIMAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMALL ANIMAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY GOVERNMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY GOVERNMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY GOVERNMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE PROVIDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE PROVIDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE PROVIDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY GENERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY GENERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY GENERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SPECIALTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SPECIALTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SPECIALTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY OUTPATIENT CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY OUTPATIENT CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY OUTPATIENT CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY OUTPATIENT CENTERS, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY AMBULATORY SURGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY AMBULATORY SURGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 217. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY AMBULATORY SURGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY REHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY REHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 220. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY REHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 222. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 223. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 225. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 226. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 227. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 228. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, 2018-2032 (USD MILLION)
  • TABLE 229. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 230. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 231. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, 2018-2032 (USD MILLION)
  • TABLE 233. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, 2018-2032 (USD MILLION)
  • TABLE 234. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, 2018-2032 (USD MILLION)
  • TABLE 235. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, 2018-2032 (USD MILLION)
  • TABLE 237. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 238. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, 2018-2032 (USD MILLION)
  • TABLE 239. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 240. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
  • TABLE 241. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 243. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 244. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 245. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 246. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY OUTPATIENT CENTERS, 2018-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 250. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 252. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, 2018-2032 (USD MILLION)
  • TABLE 254. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 256. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, 2018-2032 (USD MILLION)
  • TABLE 258. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, 2018-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, 2018-2032 (USD MILLION)
  • TABLE 260. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, 2018-2032 (USD MILLION)
  • TABLE 262. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, 2018-2032 (USD MILLION)
  • TABLE 264. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
  • TABLE 266. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 268. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 270. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY OUTPATIENT CENTERS, 2018-2032 (USD MILLION)
  • TABLE 272. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 276. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 278. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, 2018-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 280. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, 2018-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, 2018-2032 (USD MILLION)
  • TABLE 284. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, 2018-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 286. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, 2018-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 288. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, 2018-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 290. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
  • TABLE 291. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 292. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 293. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 294. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 295. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 296. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY OUTPATIENT CENTERS, 2018-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, 2018-2032 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA PORTABLE DIAGNOSTIC IMAGIN